Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

fitsCAN

Financiado

Blood flow induced thrombosis and stenosis due to cannulation – an interdiscipli...

Blood flow induced thrombosis and stenosis due to cannulation – an interdisciplinary study In extracorporeal organ support (ECOS), one or more organ functions fail and are replaced by an artificial device. Kidney failure requires hemodialysis, at least until transplantation. Temporary lung- and/or heart-failure may be t... ver más

31/08/2027

KTH

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

KUNGLIGA TEKNISKA HOEGSKOLAN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-06-03

ERC-2021-COG: ERC CONSOLIDATOR GRANTS Scope:Objectives

I+D

Cerrada hace 3 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

KTH

1.72M€ | Lider

280.35K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

BloodTurbine Fully implantable patient specific Artificial Hearts without... 150K€ Cerrado

DER2013-50411-EXP LA REGLA DEL DONANTE CADAVER Y LA DONACION DE ORGANOS TRAS L... 40K€ Cerrado

Biventricular Epicardial Augmentation Technology A revolutionary technology platform for providing life-savin... 4M€ Cerrado

BFU2009-09804 ESTUDIO EN BIORREACTOR DE LOS FENOMENOS FISICOS Y DE LAS RES... 145K€ Cerrado

PID2020-120252RB-I00 COMPRENDER Y MODULAR LA ARTERIALIZACION DURANTE EL DESARROLL... 474K€ Cerrado

DPI2010-20746-C03-01 DESARROLLO DE UNA HERRAMIENTA COMPUTACIONAL DE INTERACCION F... 159K€ Cerrado

Duración del proyecto: 62 meses Fecha Inicio: 2022-06-03
Fecha Fin: 2027-08-31

Líder del proyecto

KUNGLIGA TEKNISKA HOEGSKOLAN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Descripción del proyecto In extracorporeal organ support (ECOS), one or more organ functions fail and are replaced by an artificial device. Kidney failure requires hemodialysis, at least until transplantation. Temporary lung- and/or heart-failure may be treated by Extracorporeal Membrane Oxygenation (ECMO). About 1.5 Million patients require hemodialysis worldwide. ECMO has an essential life-saving role during the ongoing COVID-19 pandemic, as during the Influenzae H1N1 pandemic in 2009. In ECOS, two or more accesses are used; one for blood drainage and another to return oxygenated blood. The flow rate in the cannula and the cannulated blood vessels is often significantly higher than physiologically experienced. The high flow velocity implies larger forces (stress) acting on the blood cells and the vessel walls. Thromboembolism and morphological and mechanical changes in the affected blood vessel are common complications in ECOS. This project focus on the impact of blood flow on these complications. Patient-specific data (CT, MRI and Ultrasound based) will be used to construct laboratory and simulation relevant frameworks. Set-ups for measurement of flow and mixing in-vitro will be used. Simulations will include modeling of transport of chemical species and blood cells along with modeling of platelet activation and risk for thrombus formation. The different tools will enable a considerably better understanding of the underlying pathological processes. The results will support further model development of these processes and facilitate improved cannulation techniques and new devices. These propositions are to be assessed by our clinical partners. Therefore, the project group includes, fluid mechanical expertise, and also clinical specialist in nephrology, intensive care/ECMO, and radiology. The outcome of research will enable device development and clinical decision-making reducing overall treatment complications.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores